Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP1112 | DOI: 10.1530/endoabs.90.EP1112

ECE2023 Eposter Presentations Late Breaking (91 abstracts)

Metabolic Control and Perinatal Outcomes According to The Planning or Lack of Planning of The Pregnancy

Andrea Fernández Valero 1 , Víctor José Simón Frapolli 2 , Marta Generoso Piñar 2 , Maria Molina Vega 2 , Francisco J Tinahones 2 & María José Picón César 2


1Hospital Virgen de la Victoria, Malaga, Spain, 2Hospital Virgen de la Victoria, Endocrinology and Nutrition, Malaga, Spain


Objectives: To analyze the data of patients seen at the Diabetes and Pregnancy Unit, assessing the frequency of pregnancy planning and whether there are differences in the degree of metabolic control before and during pregnancy, as well as in perinatal outcomes with respect to those who do not plan. All women of childbearing age with Pregestational Diabetes Mellitus(PGDM) should receive preconception counseling to optimize glycemic control, since preconception control is associated with a reduced risk of fetal malformations and perinatal mortality. In addition, pre-existing complications and associated comorbidities should be assessed, as well as the possible use of potentially teratogenic drugs. Despite this, only a minority plan their gestation.

Materials and Methods: Retrospective observational study. Data from 72 patients seen in the Diabetes and Pregnancy Unit, between were collected and analyzed.

Outcomes: Data of 72 women of whom 86.1% were Caucasian, 6.9% Arab, 4.2% Oriental and 2.8% South American, with a mean age of 34.5+/-6.25 years. Regarding the type of PGDM, 64(88.9%) had type 1 DM and 8(11.1%) had type 2 DM, with a mean evolution of 16.34+/-8.56 years since diagnosis. Only 28(38.9%) performed a previous planning, having 26 green light by the Endocrinologist at the time of gestation.

The perinatal and metabolic control data are shown in the table.
N(72)Planning pregnancy(n=28)No planning pregnancy(n=44)P
PGDM TYPE
DM1 40.6%59.4%
DM2 25%75%
METABOLIC CONTROL
HbA1c pre-pregnancy(%)6.57+/-0.667.73+/-1.43<0.001
HbA1c 1st trimester(%)6.38+/-0.666.99+/-1.070.005
HbA1c 2nd trimester(%)6.11+/-0.536.29+/-0.760.23
HbA1c 3rd trimester(%)6.41+/-0.616.44+/-0.740.85
BMI 1st trimester(kg/m2)27.31+/-6.0724.91+/-5.770.131
BMI 2nd trimester(kg/m2)29.38+/-8.1226.85+/- 9.470.246
PREGNANCY AND PERINATAL OUTCOMES
Type of delivery0.418
Cesarean25%11.4%
Spontaneous32.1%38.6%
Induced42.9%47.7%
Weeks of gestation 37.42+/-1.8537.23+/-2.50.74
Weight(gr)3572.18+/-648.33415,88+/-825.330.40
Fetal suffering0%6.8%0.329
Major malformation0%2.3%0.472
Birth trauma0%0%0.558
Hypoglycemia 35.7%25%0.643
Respiratory distress14.3%13.7%0.581
Mortality0%4.5%(intrauterine)0.120

Conclusions: In those patients who do not plan, the initial HbA1c is significantly higher than in those who do plan. An early and close follow-up in the Diabetes and Pregnancy Unit allows improving metabolic control, achieving no significant differences at the end of gestation. No significant differences were observed in terms of perinatal adverse events, however, serious complications such as intrauterine mortality, fetal distress and major malformations occurred in those who do not plan, even though they did not reach statistical significance.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.